Chronology 13F
← Back to convictions

Alnylam Pharmaceuticals, Inc.

ALNY · Health Care

3 whale investors · Q4 2022

Whale investors

Concentrated managers reporting this company in Q4 2022.

3 holders
  1. Duquesne Family OfficeStanley Druckenmiller
    EquityQ4 2022
    $21.13M1.05% portfolio

Holdings reflect reported 13F data for Q4 2022 and may be delayed or incomplete.